nach oben

Indian Journal of Otolaryngology and Head & Neck Surgery

Erschienen in:

12.09.2023 | Original Article

Prevalence of Epstein Barr Virus and Herpes Simplex Virus Among Human Papillomavirus Negative Oral Cancer Patients: A Cross-Sectional Study from South India

verfasst von: Paras Jain, Nawin Kumar, Shriya C. Shetty, Shwetha Shetty Kalladka, Pushkal Sinduvadi Ramesh, Prakash Patil, Mohana Kumar, Vinay Kumar Rajendra, Devanand Devegowda, Veena Shetty

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

The high incidence of oral carcinomas is due to its multifactorial etiology and the presence of various risk factors. Human Papillomavirus (HPV) has a proven role in the pathogenesis of oral carcinomas, but in the recent times there has been an increasing incidence of oral cancers who are negative for HPV infection. Also, these patients are non-smokers and non-drinkers so it could be speculated that these oral cancers are due to some other etiological factor probably of other viral infections. Therefore, this study examined the prevalence of Epstein Barr Virus (EBV) and Herpes Simplex Virus (HSV) among oral cancer patients. This cross-sectional study was conducted from January 2019 to June 2020. Biopsy samples from 47 newly diagnosed untreated patients with oral malignancies were collected along with their demographic and clinicopathological information. DNA extracted from the biopsies was processed for nested PCR for the detection of EBV and HSV. All the samples tested negative for HPV and HSV infection. Nested PCR detected 29 cases (70.7%) to be positive for EBV. The non-cancerous adjacent tissues also were negative for HPV, EBV and HSV. The prevalence of EBV was found to be more in males (62.1%) and the highest number of cases was of the left buccal mucosa compromising 34% of the total cases. From the present study it can be concluded that EBV but not HSV infection is associated with an increased risk of developing oral cancers. Although, 70.7% of the patients were found to be positive for EBV whether the viral infection played any role in the driving the malignancy needs to be further elucidated.

Subash A, Bylapudi B, Thakur S, Rao VU (2022) Oral cancer in India, a growing problem: is limiting the exposure to avoidable risk factors the only way to reduce the disease burden? Oral Oncol 125:105677. https://doi.org/10.1016/j.oraloncology.2021.105677CrossRefPubMed

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660CrossRef

Barrios R, Bravo M, Gil-Montoya JA, Martínez-Lara I, García-Medina B, Tsakos G (2015) Oral and general health-related quality of life in patients treated for oral cancer compared to control group. Health Qual Life Outcomes 13(1):1–8. https://doi.org/10.1186/s12955-014-0201-5CrossRef

Moore K, Ford P, Farah C (2014) Support needs and quality of life in oral cancer: a systematic review. Int J Dental Hygiene 12(1):36–47. https://doi.org/10.1111/idh.12051CrossRef

Anantharaman D, Chabrier A, Gaborieau V, Franceschi S, Herrero R, Rajkumar T et al (2014) Genetic variants in nicotine addiction and alcohol metabolism genes, oral cancer risk and the propensity to smoke and drink alcohol: a replication study in India. PLoS ONE 9(2):e88240. https://doi.org/10.1371/journal.pone.0088240ADSCrossRefPubMedPubMedCentral

Lee CH, Ko AMS, Warnakulasuriya S, Yin BL, Zain RB, Ibrahim SO et al (2011) Intercountry prevalences and practices of betel-quid use in south, southeast and eastern Asia regions and associated oral preneoplastic disorders: an international collaborative study by asian betel‐quid consortium of south and east Asia. Int J Cancer 129(7):1741–1751. https://doi.org/10.1002/ijc.25809CrossRefPubMed

Sankaranarayanan R, Ramadas K, Amarasinghe H, Subramanian S, Johnson N (2015) Oral cancer: prevention, early detection, and treatment. Cancer: disease control priorities, third edition (volume 3). https://doi.org/10.1596/978-1-4648-0349-9_ch5

Hillbertz NS, Hirsch J-M, Jalouli J, Jalouli MM, Sand L (2012) Viral and molecular aspects of oral cancer. Anticancer Res 32(10):4201–4212PubMed

Giuliano AR, Nyitray AG, Kreimer AR, Pierce Campbell CM, Goodman MT, Sudenga SL et al (2015) E UROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Int J Cancer 136(12):2752–2760. https://doi.org/10.1002/ijc.29082CrossRefPubMed

10.

Gillison ML, Shah KV (2001) Human papillomavirus–associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr Opin Oncol 13(3):183–188. https://doi.org/10.1097/00001622-199905000-00010CrossRefPubMed

11.

Westra WH (2009) The changing face of head and neck cancer in the 21st century: the impact of HPV on the epidemiology and pathology of oral cancer. Head Neck Pathol 3(1):78–81. https://doi.org/10.1007/s12105-009-0100-yCrossRefPubMedPubMedCentral

12.

Herrero R, Castellsagué X, Pawlita M, Lissowska J, Kee F, Balaram P et al (2003) Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 95(23):1772–1783. https://doi.org/10.1093/jnci/djg107CrossRefPubMed

13.

Bandhary SK, Shetty V, Saldanha M, Gatti P, Devegowda D, Pushkal S et al (2018) Detection of human papilloma virus and risk factors among patients with head and neck squamous cell carcinoma attending a tertiary referral centre in South India. Asian Pac J cancer Prevention: APJCP 19(5):1325. https://doi.org/10.22034/APJCP.2018.19.5.1325CrossRef

14.

Nagpal JK, Patnaik S, Das BR (2002) Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphisms in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India. Int J Cancer 97(5):649–653. https://doi.org/10.1002/ijc.10112CrossRefPubMed

15.

Sannigrahi M, Singh V, Sharma R, Panda N, Radotra B, Khullar M (2016) Detection of active human papilloma virus-16 in head and neck cancers of asian north indian patients. Oral Dis 22(1):62–68. https://doi.org/10.1111/odi.12382CrossRefPubMed

16.

Ramesh PS, Devegowda D, Naik PR, Doddamani P, Nataraj SM (2018) Evaluating the feasibility of nested PCR as a screening tool to detect HPV infection in saliva of oral squamous cell carcinoma subjects. J Clin Diagnostic Res 12. https://doi.org/10.7860/JCDR/2018/34880.11806

17.

Ajila V, Babu S, Shetty V, Shetty P, Devegowda D, Ramesh P et al (2021) Human papillomavirus in oral squamous cell carcinoma: an institutional study. Clin Cancer Invest J 10(3):102–108. https://doi.org/10.4103/ccij.ccij_152_20CrossRef

18.

Laprise C, Madathil SA, Allison P, Abraham P, Raghavendran A, Shahul HP et al (2016) No role for human papillomavirus infection in oral cancers in a region in southern I ndia. Int J Cancer 138(4):912–917. https://doi.org/10.1002/ijc.29827CrossRefPubMed

19.

Sand L, Jalouli J (2014) Viruses and oral cancer. Is there a link? Microbes Infect 16(5):371–378. https://doi.org/10.1016/j.micinf.2014.02.009CrossRefPubMed

20.

Slots J, Saygun I, Sabeti M, Kubar A (2006) Epstein–Barr virus in oral diseases. J Periodontal Res 41(4):235–244. https://doi.org/10.1111/j.1600-0765.2006.00865.xCrossRefPubMed

21.

Guidry JT, Birdwell CE, Scott RS (2018) Epstein–Barr virus in the pathogenesis of oral cancers. Oral Dis 24(4):497–508. https://doi.org/10.1111/odi.12656CrossRefPubMed

22.

Roughan JE, Thorley-Lawson DA (2009) The intersection of Epstein-Barr virus with the germinal center. J Virol 83(8):3968–3976. https://doi.org/10.1128/JVI.02609-08CrossRefPubMedPubMedCentral

23.

Thorley-Lawson DA, Hawkins JB, Tracy SI, Shapiro M (2013) The pathogenesis of Epstein–Barr virus persistent infection. Curr Opin Virol 3(3):227–232. https://doi.org/10.1016/j.coviro.2013.04.005CrossRefPubMedPubMedCentral

24.

Khammissa RAG, Fourie J, Chandran R, Lemmer J, Feller L (2016) Epstein-Barr virus and its association with oral hairy leukoplakia: a short review. International Journal of Dentistry. ;2016. https://doi.org/10.1155/2016/4941783

25.

Mundo L, Del Porro L, Granai M, Siciliano MC, Mancini V, Santi R et al (2020) Frequent traces of EBV infection in Hodgkin and non-hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas. Mod Pathol 33(12):2407–2421. https://doi.org/10.1038/s41379-020-0575-3CrossRefPubMedPubMedCentral

26.

Busson P, Keryer C, Ooka T, Corbex M (2004) EBV-associated nasopharyngeal carcinomas: from epidemiology to virus-targeting strategies. Trends Microbiol 12(8):356–360. https://doi.org/10.1016/j.tim.2004.06.005CrossRefPubMed

27.

Wilson AC, Mohr I (2012) A cultured affair: HSV latency and reactivation in neurons. Trends Microbiol 20(12):604–611. https://doi.org/10.1016/j.tim.2012.08.005CrossRefPubMedPubMedCentral

28.

Whitley RJ, Roizman B (2001) Herpes simplex virus infections. The Lancet 357(9267):1513–1518. https://doi.org/10.1016/S0140-6736(00)04638-9CrossRef

29.

Grinde B (2013) Herpesviruses: latency and reactivation–viral strategies and host response. J oral Microbiol 5(1):22766. https://doi.org/10.3402/jom.v5i0.22766CrossRef

30.

Niller HH, Wolf H, Minarovits J (2011) Viral hit and run-oncogenesis: genetic and epigenetic scenarios. Cancer Lett 305(2):200–217. https://doi.org/10.1016/j.canlet.2010.08.007CrossRefPubMed

31.

Jain M (2016) Assesment of correlation of herpes simplex virus-1 with oral cancer and precancer-a comparative study. J Clin Diagn Research: JCDR 10(8):ZC14. https://doi.org/10.7860/JCDR/2016/18593.8229CrossRef

32.

Gupta B, Ariyawardana A, Johnson NW (2013) Oral cancer in India continues in epidemic proportions: evidence base and policy initiatives. Int Dent J 63(1):12–25. https://doi.org/10.1111/j.1875-595x.2012.00131.xCrossRefPubMed

33.

Gupta B, Bray F, Kumar N, Johnson NW (2017) Associations between oral hygiene habits, diet, tobacco and alcohol and risk of oral cancer: a case–control study from India. Cancer Epidemiol 51:7–14. https://doi.org/10.1016/j.canep.2017.09.003CrossRefPubMed

34.

Michaud DS, Langevin SM, Eliot M, Nelson HH, Pawlita M, McClean MD et al (2014) High-risk HPV types and head and neck cancer. Int J Cancer 135(7):1653–1661. https://doi.org/10.1002/ijc.28811CrossRefPubMedPubMedCentral

35.

Fakhry C, Gillison ML (2006) Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncology: Official J Am Soc Clin Oncol 24(17):2606. https://doi.org/10.1200/JCO.2006.06.1291CrossRef

36.

Wang MB, Liu IY, Gornbein JA, Nguyen CT (2015) HPV-positive oropharyngeal carcinoma: a systematic review of treatment and prognosis. Otolaryngology–Head and Neck Surgery 153(5):758–769. https://doi.org/10.1177/0194599815592157CrossRefPubMed

37.

Kimple RJ, Smith MA, Blitzer GC, Torres AD, Martin JA, Yang RZ et al (2013) Enhanced radiation sensitivity in HPV-positive head and neck cancer. Cancer Res 73(15):4791–4800. https://doi.org/10.1158/0008-5472.CAN-13-0587CrossRefPubMedPubMedCentral

38.

Ramesh PS, Devegowda D, Singh A, Thimmulappa RK (2020) NRF2, p53, and p16: predictive biomarkers to stratify human papillomavirus associated head and neck cancer patients for de-escalation of cancer therapy. Crit Rev Oncol/Hematol 148:102885. https://doi.org/10.1016/j.critrevonc.2020.102885CrossRefPubMed

39.

Humme S, Reisbach G, Feederle R, Delecluse H-J, Bousset K, Hammerschmidt W et al (2003) The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold. Proceedings of the National Academy of Sciences. 100(19):10989-94. https://doi.org/10.1073/pnas.1832776100

40.

Frappier L (2012) Contributions of Epstein–Barr nuclear antigen 1 (EBNA1) to cell immortalization and survival. Viruses 4(9):1537–1547. https://doi.org/10.3390/v4091537CrossRefPubMedPubMedCentral

41.

She Y, Nong X, Zhang M, Wang M (2017) Epstein-Barr virus infection and oral squamous cell carcinoma risk: a meta-analysis. PLoS ONE 12(10):e0186860. https://doi.org/10.1371/journal.pone.0186860CrossRefPubMedPubMedCentral

42.

Prathyusha MM, Kattappagari KK, Chowdary D, Shekar PC, Alivelu D, Reddy BVR (2019) A study on association of epstein barr virus in oral squamous cell carcinoma using polymerase chain reaction technique. J Dr NTR Univ Health Sci 8(4):233. https://doi.org/10.4103/JDRNTRUHS.JDRNTRUHS_102_18CrossRef

43.

Reddy SS, Sharma S, Mysorekar V (2017) Expression of Epstein–Barr virus among oral potentially malignant disorders and oral squamous cell carcinomas in the south indian tobacco-chewing population. J Oral Pathol Med 46(6):454–459. https://doi.org/10.1111/jop.12508CrossRefPubMed

44.

Starr JR, Daling JR, Fitzgibbons ED, Madeleine MM, Ashley R, Galloway DA et al (2001) Serologic evidence of herpes simplex virus 1 infection and oropharyngeal cancer risk. Cancer Res 61(23):8459–8464PubMed

45.

Mokhtari M, Beiraghdar M (2015) Evaluation of the prevalence of herpes simplex-1 infection in oral squamous cell carcinoma specimens in Alzahra and Kashani Hospitals with polymerase chain reaction method in 2012–2013. Adv Biomedical Res 4. https://doi.org/10.4103/2277-9175.163996

46.

Gondivkar SM, Parikh RV, Gadbail AR, Solanke V, Chole R, Mankar M, Balsaraf S (2012) Involvement of viral factors with head and neck cancers. Oral Oncol 48(3):195–199. https://doi.org/10.1016/j.oraloncology.2011.10.007CrossRefPubMed

47.

Gupta K, Metgud R (2013) Evidences suggesting involvement of viruses in oral squamous cell carcinoma. Pathology research international. 2013. https://doi.org/10.1155/2013/642496

48.

Jalouli J, Ibrahim SO, Mehrotra R, Jalouli MM, Sapkota D, Larsson P-A et al (2010) Prevalence of viral (HPV, EBV, HSV) infections in oral submucous fibrosis and oral cancer from India. Acta Otolaryngol 130(11):1306–1311. https://doi.org/10.3109/00016481003782041CrossRefPubMed

49.

Jalouli J, Jalouli MM, Sapkota D, Ibrahim SO, Larsson P-A, Sand L (2012) Human papilloma virus, herpes simplex virus and epstein barr virus in oral squamous cell carcinoma from eight different countries. Anticancer Res 32(2):571–580PubMed

Titel: Prevalence of Epstein Barr Virus and Herpes Simplex Virus Among Human Papillomavirus Negative Oral Cancer Patients: A Cross-Sectional Study from South India
verfasst von: Paras Jain
Nawin Kumar
Shriya C. Shetty
Shwetha Shetty Kalladka
Pushkal Sinduvadi Ramesh
Prakash Patil
Mohana Kumar
Vinay Kumar Rajendra
Devanand Devegowda
Veena Shetty
Publikationsdatum: 12.09.2023
Verlag: Springer India
Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe 1/2024
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI: https://doi.org/10.1007/s12070-023-04174-6

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Prevalence of Epstein Barr Virus and Herpes Simplex Virus Among Human Papillomavirus Negative Oral Cancer Patients: A Cross-Sectional Study from South India

Abstract

Neu im Fachgebiet HNO

Akuter Schwindel: Wann lohnt sich eine MRT?

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Update HNO

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2024

Experience of Island Nasolabial Flap for Patients with Oral Cavity Cancer

Normalcy in Post-operative Period After Bilateral IJV Ligation: A Rare Case Report

Cross-Cultural Adaptation, Translation and Validation of Kannada Version of the Swallowing Quality of Life Questionnaire (KSWAL-QOL)

Beyond the Norm: Tracheostomy’s Vital Role in Unconventional Foreign Body Removal

Misplaced Intracystic Lacrimal Implant- An Unusual Cause of Failed External Dacryocystorhinostomy

Safety and Efficacy of Autologous Cartilage Graft in Augmentation Rhinoplasty

Neu im Fachgebiet HNO

Akuter Schwindel: Wann lohnt sich eine MRT?

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Update HNO